Laserfiche WebLink
Proving What’s Possible in Healthcare <br />This document contains important terms and conditions which are incorporated by reference into and becomes <br />part of the terms of your contract with us. ©2024, Healthcare Management Administrators, Inc. <br />2025 additional pricing, terms and conditions <br />Vaccine Availability and Pricing: <br />•If elected by the Participating Group in the PDD, CVS Caremark shall provide vaccine administration services in <br />accordance with such elections. Vaccines administered by Participating Pharmacies shall be adjudicated using the <br />same AWP discount and dispensing fee as would a standard 30-day supply Brand Drug Claim plus a $20 <br />administration fee. This administration fee can adjust seasonally (usually in August or September of each year), and <br />CVS Caremark shall provide Participating Group written notification of such change prior to the effective date of the <br />change and Participating Group shall have fifteen (15) days from receipt of such notification to make any changes in <br />its vaccine program elections, including terminating its participation in the vaccine program, which changes, if any, <br />shall be made by written notification to CVS Caremark. If Participating Group does not elect to change its vaccine <br />program elections, the charges in CVS Caremark’s notification to Participating Group shall apply to any vaccinations <br />administered to Plan Participants on and after the effective date set forth in CVS Caremark’s notification. Caremark <br />Retail-90, CVS-90, Maintenance Choice and other 90-day network pricing terms, if any, do not apply to vaccines. <br />Participating Group may, upon at least thirty (30) days’ prior written notice to CVS Caremark, terminate participation <br />in the vaccine program at any time. <br />•Vaccine Program Management fee of $0.05 per member per month. <br />Rebates: <br />•Participating Group will receive the aggregate value of the rebates quoted herein. Rebate guarantees are <br />conditioned upon alignment with CVS Caremark Formulary –Standard Control Choice, where applicable, alignment <br />with CVS Caremark Advanced Control Choice Formulary, where applicable, alignment with CVS Caremark Formulary <br />–Basic Control, where applicable, alignment with CVS Caremark Formulary –Standard Formulary Opt Out, where <br />applicable, alignment with CVS Caremark Advanced Control Specialty Formulary , where applicable, and the Claims <br />utilization mix and volume available at the time of pricing negotiations remaining consistent through the Term of the <br />Agreement. <br />•Rebate guarantees are contingent upon CVS Caremark’s ability to collect Rebates from pharmaceutical companies <br />not being materially adversely impacted by legislative, regulatory, or judicial action, and continued full <br />pharmaceutical company participation. In the event these conditions are not met, CVS Caremark reserves the right <br />to equitably adjust the Rebate guarantees. <br />•Additional 340B exclusions may be identified and true-up may occur, after Rebates are paid. Rebate guarantees are <br />paid quarterly for each channel. <br />•Specialty Rebates will not be paid in instances which Administrator's Participating Group does not have a Specialty <br />Pharmacy Benefit. <br />Rebate Timing: Rebates are sent from CVS Caremark to us on a quarterly basis and are credited to the Participating <br />Group’s administrative fees. Q1 will pay in Q3, Q2 will pay in Q4, Q3 will pay in Q1, Q4 will pay in Q2. Please note this <br />payment timing is guidance only and actual timing will depend upon CVS Caremark’s timeliness and our review of <br />rebating reporting. <br />Rebate Exclusions: 340B Claims and any other Claim identified as having received 340B program pricing, Compound <br />drug Claims, Paper or Member submitted Claims, Coordination of Benefits (COB) or secondary payor Claims, Limited <br />distribution and exclusive distribution drugs, Vaccine (including COVID) and vaccine administration claims, COVID <br />treatment claims, Biosimilar Claims (applicable only to groups aligned to CVS Caremark Formulary –Standard Formulary <br />Opt-Out), Over the Counter (OTC) product Claims, and Claims approved by formulary exception are also excluded from <br />rebates. Specialty Rebates will not be paid in instances which HMA's Participating Group does not have a Specialty <br />Pharmacy Benefit. <br />* Please Note: <br />•Please see Participating Group Agreement and supplemental documents for full Terms and Conditions <br />27 <br />Additional Terms and Conditions as follows are for clients on our contract and <br />are effective January 2025 –December 2025. <br />Pharmacy Benefits